Effectiveness, safety and predictors of response to vedolizumab as first- or second-line biological therapy in patients with ulcerative colitis: A real-world observational multicenter study.
Loading...
Files
External sources
External sources
Date
Advisor
Coadvisor
Graduate program
Undergraduate course
Journal Title
Journal ISSN
Volume Title
Publisher
Oxford Univ Press
Type
Abstract
Access right
Files
External sources
External sources
Abstract
Description
Keywords
Language
English
Citation
Journal Of Crohns & Colitis. Oxford: Oxford Univ Press, v. 19, p. i1335-i1336, 2025.
